A novel Bruton's tyrosine kinase inhibitor CC-292 in combination with the proteasome inhibitor carfilzomib impacts the bone microenvironment in a multiple myeloma model with resultant antimyeloma activity (Q39024879)
Jump to navigation
Jump to search
scientific article published on 12 February 2014
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A novel Bruton's tyrosine kinase inhibitor CC-292 in combination with the proteasome inhibitor carfilzomib impacts the bone microenvironment in a multiple myeloma model with resultant antimyeloma activity |
scientific article published on 12 February 2014 |
Statements
1 reference
A novel Bruton's tyrosine kinase inhibitor CC-292 in combination with the proteasome inhibitor carfilzomib impacts the bone microenvironment in a multiple myeloma model with resultant antimyeloma activity (English)
1 reference
H Eda
1 reference
L Santo
1 reference
D D Cirstea
1 reference
A J Yee
1 reference
T A Scullen
1 reference
N Nemani
1 reference
Y Mishima
1 reference
P R Waterman
1 reference
S Arastu-Kapur
1 reference
E Evans
1 reference
J Singh
1 reference
C J Kirk
1 reference
W F Westlin
1 reference
N S Raje
1 reference
12 February 2014
1 reference
1 reference
28
1 reference
9
1 reference
1892-1901
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference